Response to L-glutamate

pathway activity — cross-omics
GO:1902065Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to L-glutamate pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RUNX2, PCDH7, and MMP19, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to L-glutamate activity versus RUNX2 in LSCC (Pearson r = -0.22).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCRUNX2 →-0.510-0.577.001.00734
HNSCPCDH7 →-1.002-0.510.002.00534
BRCAMMP19 →-0.722-0.550<.001.00134
BRCAGFPT2 →-0.619-0.517<.001<.00134
BRCAMYO1E →-0.442-0.537<.001<.00134
BRCACOL3A1 →-1.035-0.542.001.00434
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1902065 vs RUNX2 — LSCC

Per-sample scatter of Response to L-glutamate activity vs RUNX2 in LSCC.

Explore this scatter interactively →

Exploration